[Inhibitory effect of toll-like receptor 7 agonist on K562 cells].

Zhongguo Shi Yan Xue Ye Xue Za Zhi

Tumor Immunotherapy Center, Hospital 97 of Chinese PLA, Xuzhou, Jiangsu Province, China.

Published: June 2012

The aim of this study was to investigate the inhibitory effect of Toll-like receptor 7 (TLR7) agonist gardiquimod on K562 cells. Human γδT cells from peripheral blood cells were amplified by isopentenyl pyrophosphate. The proliferation capacity of γδT cells and K562 cells were measured with MTT assay after treatment with different concentrations of gardiquimod. Cytotoxicity of γδT cells on K562 cells was detected by CCK-8 kit, and the intracellular expression of TLR7, cell cycle and apoptosis of K562 cells before and after treatment with gardiquimod were measured by flow cytometry. The results demonstrated that gardiquimod could significantly stimulate the proliferation of γδT cells, and inhibit proliferation of K562 cells under the concentration of 11.0 µg/ml for 48 h. The expression of TLR7 increased after treatment with gardiquimod. No apoptosis was observed, but there were significant changes in cell cycle, moreover the K562 cells treated with gardiquimod were more killed by γδT cells. It is concluded that the gardiquimod can inhibit the proliferation of K562 cells and enhance their sensitivity to killing activity of human γδT cells.

Download full-text PDF

Source

Publication Analysis

Top Keywords

k562 cells
28
γδt cells
24
cells
14
toll-like receptor
8
k562
8
human γδt
8
cells k562
8
expression tlr7
8
cell cycle
8
treatment gardiquimod
8

Similar Publications

Fucosyltransferase 4 upregulates P-gp expression for chemoresistance via NF-κB signaling pathway.

Biochim Biophys Acta Gen Subj

December 2024

Division of Regulatory Glycobiology, Graduate School of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Japan; Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai, Miyagi 981-8558, Japan. Electronic address:

Article Synopsis
  • Multidrug resistance (MDR) complicates the development of effective chemotherapy, with previous research showing that GnT-III expression decreases chemoresistance and that fucosylation is heightened in resistant cell models.
  • Using advanced techniques like CRISPR/Cas9, this study created a FUT4 knockout cell line to assess how fucosylation affects drug resistance by analyzing various gene expressions and drug response.
  • The findings revealed that knocking out FUT4 lowered P-glycoprotein levels and enhanced drug sensitivity, indicating that FUT4 plays a pivotal role in regulating P-glycoprotein expression through the NF-κB signaling pathway, positioning it as a potential target for overcoming MDR in cancer treatment.
View Article and Find Full Text PDF

This comprehensive study focused on evaluating and selecting seven distinct commercial membranes to develop BTESE/PA membranes. This method effectively facilitated the extraction of cynaroside from the complex composition of peony seed meal. We subsequently conducted a thorough investigation into its biological properties.

View Article and Find Full Text PDF

Hydrogels are adaptable substances with a 3D framework able to hold large quantities of water, which is why they are ideal for use in the field of biomedicine. This research project focused on creating a new hydrogel combining carboxymethyl chitosan (CMCS), graphene quantum dots (GQDs), pectin (Pe), and MIL-88 for precise and controlled release of the cancer drug doxorubicin (DOX). The creation of CMCS/GQDs@Pe/MIL-88 hydrogel beads was achieved through an eco-friendly one-step synthesis method.

View Article and Find Full Text PDF

A new regulation mechanism for KCNN4, the Ca-dependent K channel, by molecular interactions with the Capump PMCA4b.

J Biol Chem

December 2024

Université Côte d'Azur, CNRS, Inserm, Institut Biologie Valrose, Nice, France; Laboratory of Excellence for RBC, LABEX GR-Ex, 75015, Paris, France. Electronic address:

KCNN4, a Ca-activated K channel, is involved in various physiological and pathological processes. It is essential for epithelial transport, immune system and other physiological mechanisms but its activation is also involved in cancer pathophysiology as well as red blood cell disorders (RBC). The activation of KCNN4 in RBC leads to loss of KCl and water, a mechanism known as the "Gardos effect" described seventy years ago.

View Article and Find Full Text PDF

ID3 promotes erythroid differentiation and is repressed by a TAL1/PRMT6 complex.

J Biol Chem

December 2024

University of Stuttgart, Institute of Biomedical Genetics, Department of Eukaryotic Genetics, Allmandring 31, 70569 Stuttgart, Germany. Electronic address:

Erythropoiesis is controlled by transcription factors that recruit epigenetic cofactors to establish and maintain erythrocyte-specific gene expression patterns while repressing alternative lineage commitment. The transcription factor TAL1 is critical for establishing erythroid gene expression. It acts as an activator or repressor of genes, depending on associated epigenetic cofactors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!